Biotech

All Articles

Rivus' period 2 obesity-related heart failure test reaches endpoint

.Rivus Pharmaceuticals has plumped up the potential customers of its fat-busting, muscle-sparing med...

Ovid stops preclinical job, IV plan after soticlestat stop working

.Ovid Therapy actually revealed last month that it was trimming its head count as the provider gets ...

Eli Lilly opens $700M nucleic acid R&ampD facility in Boston Port

.Eli Lilly has opened a $700 million R&ampD center in the Boston Seaport, enhancing its RNA and also...

Boundless Bio makes 'small' discharges five months after $100M IPO

.Just 5 months after protecting a $one hundred thousand IPO, Limitless Biography is actually present...

Halda's $126M will advance 'secure and eliminate' growth medications

.The initial phases of oncology R&ampD may not be except appealing brand-new techniques, as well as ...

Lykos 'regrets' certainly not making known research study infractions with publisher

.Psychopharmacology has taken 3 articles concerning midstage clinical test information examining Lyk...

Analysts explore Avidity's DMD win, revealing distinctions in information

.Avidity Biosciences impressed entrepreneurs along with phase 1/2 information in Duchenne muscle dys...

Actinogen's cortisol blocker stops working phase 2 clinical depression research study

.Actinogen Medical's cortisol blocker has actually missed the key endpoint of a phase 2 study in cli...

Bivictrix makes a decision going exclusive only means to take ADC into clinic

.Antibody-drug conjugates (ADCs) have actually been at the facility of lots of a billion-dollar biob...

TPG bests up funds to $580M for expenditures across life scientific researches

.Resource manager TPG, which has actually supported biotechs like Sionna Rehabs and Santa Clam Ana B...